These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35243658)

  • 1. Repetitive milrinone therapy in ambulatory advanced heart failure patients.
    Laufer-Perl M; Sadon S; Zahler D; Milwidsky A; Sadeh B; Sapir O; Granot Y; Korotetski L; Ketchker L; Rosh M; Banai S; Havakuk O
    Clin Cardiol; 2022 May; 45(5):488-494. PubMed ID: 35243658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients.
    Milwidsky A; Frydman S; Laufer-Perl M; Sadeh B; Sapir O; Granot Y; Hochstadt A; Korotetski L; Ketchker L; Topilsky Y; Banai S; Havakuk O
    ESC Heart Fail; 2022 Apr; 9(2):1487-1491. PubMed ID: 35083882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Ambulatory Intravenous Milrinone Therapy in Advanced Heart Failure.
    Shringi S; Joshi S; Suffredini JM; Schenk A; Rajagopalan N; Guglin M
    Heart Lung Circ; 2022 Dec; 31(12):1630-1639. PubMed ID: 36229299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
    Kumar A; Choudhary G; Antonio C; Just V; Jain A; Heaney L; Papp MA
    Am Heart J; 2001 Sep; 142(3):512-5. PubMed ID: 11526366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
    López-Candales AL; Carron C; Schwartz J
    Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study.
    López-Candales A; Vora T; Gibbons W; Carron C; Simmons P; Schwartz J
    J Med; 2002; 33(1-4):129-46. PubMed ID: 12939113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure.
    Lee EC; McNitt S; Martens J; Bruckel JT; Chen L; Alexis JD; Storozynsky E; Thomas S; Gosev I; Barrus B; Goldenberg I; Vidula H
    Int J Cardiol; 2020 Aug; 313():83-88. PubMed ID: 32320777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.
    Acharya D; Sanam K; Revilla-Martinez M; Hashim T; Morgan CJ; Pamboukian SV; Loyaga-Rendon RY; Tallaj JA
    Am J Cardiol; 2016 Mar; 117(6):952-6. PubMed ID: 26810859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
    Cuffe MS; Califf RM; Adams KF; Benza R; Bourge R; Colucci WS; Massie BM; O'Connor CM; Pina I; Quigg R; Silver MA; Gheorghiade M;
    JAMA; 2002 Mar; 287(12):1541-7. PubMed ID: 11911756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Outpatient Milrinone Infusion in End-Stage Heart Failure: ICD-Level Data on Atrial Fibrillation and Ventricular Tachyarrhythmias.
    Harhash AA; Cassuto J; Hussein A; Achu E; Zucker MJ; Goldschmidt M; Alpert JS; Baran DA
    Am J Med; 2020 Jul; 133(7):857-864. PubMed ID: 31883773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scheduled intermittent inotropes for Ambulatory Advanced Heart Failure. The RELEVANT-HF multicentre collaboration.
    Oliva F; Perna E; Marini M; Nassiacos D; Cirò A; Malfatto G; Morandi F; Caico I; Perna G; Meloni S; Vincenzi A; Villani A; Vecchi AL; Minoia C; Verde A; De Maria R;
    Int J Cardiol; 2018 Dec; 272():255-259. PubMed ID: 30131229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended Release Oral Milrinone, CRD-102, for Advanced Heart Failure.
    Nanayakkara S; Mak V; Crannitch K; Byrne M; Kaye DM
    Am J Cardiol; 2018 Sep; 122(6):1017-1020. PubMed ID: 30064857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction.
    Cox ZL; Calcutt MW; Morrison TB; Akers WS; Davis MB; Lenihan DJ
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):433-8. PubMed ID: 23695773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral milrinone for management of refractory right ventricular failure in patients with left ventricular assist devices.
    Akhtar W; Butcher C; Morley-Smith A; Riesgo Gil F; Dar O; Baston V; Dunning J; Lyster H
    ESC Heart Fail; 2022 Dec; 9(6):4340-4343. PubMed ID: 35906098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous milrinone in treatment of advanced congestive heart failure.
    Zewail AM; Nawar M; Vrtovec B; Eastwood C; Kar MN; Delgado RM
    Tex Heart Inst J; 2003; 30(2):109-13. PubMed ID: 12809251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
    Sami F; Acharya P; Noonan G; Maurides S; Al-Masry AA; Bajwa S; Parimi N; Boda I; Tran C; Goyal A; Mastoris I; Dalia T; Sauer A; Bakel AV; Shah Z
    J Card Fail; 2022 Dec; 28(12):1683-1691. PubMed ID: 36122816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.
    Cesario D; Clark J; Maisel A
    Am Heart J; 1998 Jan; 135(1):121-9. PubMed ID: 9453531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.